Brief: FDA Approved Revance Therapeutics's Prior-Approval Supplement For Ajinomoto Althaea Doing Business As Ajinomoto Bio-Pharma Services
19/04/2023 21:15
April 19 (Reuters) - Revance Therapeutics Inc RVNC.O :
* REVANCE THERAPEUTICS - FDA APPROVED CO'S PRIOR-APPROVAL
SUPPLEMENT FOR AJINOMOTO ALTHAEA DOING BUSINESS AS AJINOMOTO
BIO-PHARMA SERVICES
Further company coverage: RVNC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revance Therapeutics
See all newsBrief: Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
Brief: Crown Laboratories And Revance Amend A&R Merger Agreement
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Kratos, Forward Air, Bank stocks
U.S. STOCKS ON THE MOVE-Henry Schein, natgas firms, Citigroup